Skip to main content
Top
Published in: Esophagus 1/2015

01-01-2015 | Original Article

Optimal duration of prophylactic antimicrobial administration and risk of postoperative infectious events in thoracic esophagectomy with three-field lymph node dissection: short-course versus prolonged antimicrobial administration

Authors: Takeo Fujita, Hiroyuki Daiko

Published in: Esophagus | Issue 1/2015

Login to get access

Abstract

Background

For prevention of surgical site infections, the current guidelines of Center of Disease Control recommend the maintenance of therapeutic levels of prophylactic antimicrobial agents throughout operations and, at most, for a few hours after incision closure. However, in literature supporting these recommendations, most reports have described combinations of various types of surgical procedures. Consequently, the optimal duration of prophylactic antimicrobial administration in esophagectomy with three-field lymph node dissection has not been fully addressed.

Methods

We randomly assigned 257 patients with esophageal cancer who underwent esophagectomy with three-field lymph node dissection into two groups and analyzed the incidences of surgical site and remote infections. Antimicrobial administration began 30 min before the skin incision was made and repeated every 3 h during the procedure in the short-course administration group, whereas additional administration was postoperatively continued the day after operation in the prolonged administration group.

Results

Among the 128/129 patients in the short-course/prolonged administration group, surgical site infections occurred in 26.5 %/24.0 % (p = 0.64), anastomotic leakage in 11.7 %/15.5 % (p = 0.37), and incisional surgical site infections in 14.8 %/8.5 % patients, respectively (p = 0.11). Remote infections occurred in 11.7 %/11.6 % (p = 0.86) patients, respectively, and the median postoperative hospital stay was 14 days (p = 0.86) in both groups.

Conclusions

In esophagectomy with three-field lymph node dissection, short-course antimicrobial administration was sufficient for the prevention of postoperative infectious events.
Literature
1.
2.
go back to reference Lewis RT, Allan CM, Goodall RG, Marien B, Park M, Lloyd-Smith W, Wiegand FM. Cefamandole in gastroduodenal surgery: a controlled, prospective, randomized, double-blind study. Can J Surg. 1982;25:561–3.PubMed Lewis RT, Allan CM, Goodall RG, Marien B, Park M, Lloyd-Smith W, Wiegand FM. Cefamandole in gastroduodenal surgery: a controlled, prospective, randomized, double-blind study. Can J Surg. 1982;25:561–3.PubMed
3.
go back to reference Nichols RL, Webb WR, Jones JW, Smith JW, LoCicero J 3rd. Efficacy of antibiotic prophylaxis in high risk gastroduodenal operations. Am J Surg. 1982;143:94–8.CrossRefPubMed Nichols RL, Webb WR, Jones JW, Smith JW, LoCicero J 3rd. Efficacy of antibiotic prophylaxis in high risk gastroduodenal operations. Am J Surg. 1982;143:94–8.CrossRefPubMed
4.
go back to reference Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, centers for disease control and prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;1999(27):97–132.CrossRef Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, centers for disease control and prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;1999(27):97–132.CrossRef
5.
go back to reference Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706–15.CrossRefPubMed Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706–15.CrossRefPubMed
6.
go back to reference Müller JM, Erasmi M, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990;77:845–57.CrossRefPubMed Müller JM, Erasmi M, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990;77:845–57.CrossRefPubMed
7.
go back to reference Fujita T, Daiko H. Early enteral nutrition reduces the rate of life-threatening complications after thoracic esophagectomy in patients with esophageal cancer. Eur Surg Res. 2012;48:79–84.CrossRefPubMed Fujita T, Daiko H. Early enteral nutrition reduces the rate of life-threatening complications after thoracic esophagectomy in patients with esophageal cancer. Eur Surg Res. 2012;48:79–84.CrossRefPubMed
8.
go back to reference Uemura Y, Ishida Y, Suzuki Y, Yanaga K. Impact of mupirocin for radical esophagectomy. J Infect Chemother. 2006;12:257–63.CrossRef Uemura Y, Ishida Y, Suzuki Y, Yanaga K. Impact of mupirocin for radical esophagectomy. J Infect Chemother. 2006;12:257–63.CrossRef
9.
go back to reference Daiko H, Nishimura M. A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma. Surg Endosc. 2012;26:673–80.CrossRefPubMed Daiko H, Nishimura M. A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma. Surg Endosc. 2012;26:673–80.CrossRefPubMed
10.
go back to reference Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326:281–6.CrossRefPubMed Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326:281–6.CrossRefPubMed
11.
go back to reference Neoral C, Horakova M, Aujesky R, Chudacek J, Hanulik V, Chroma M, Kolar M. Infectious complications after esophagectomy. Surg Infect. 2012;13:159–62. Neoral C, Horakova M, Aujesky R, Chudacek J, Hanulik V, Chroma M, Kolar M. Infectious complications after esophagectomy. Surg Infect. 2012;13:159–62.
12.
go back to reference Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, Banerjee SN, Edwards JR. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance Systems. Am J Med. 1991;91:152S–7S.CrossRefPubMed Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, Banerjee SN, Edwards JR. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance Systems. Am J Med. 1991;91:152S–7S.CrossRefPubMed
13.
go back to reference Nichols RL, Smith JW, Muzik AC, Love EJ, McSwain NE, Timberlake G, Flint LM. Prevention antibiotic use in traumatic thoracic injuries requiring closed tube thoracostomy. Chest. 1994;106:1493–8.CrossRefPubMed Nichols RL, Smith JW, Muzik AC, Love EJ, McSwain NE, Timberlake G, Flint LM. Prevention antibiotic use in traumatic thoracic injuries requiring closed tube thoracostomy. Chest. 1994;106:1493–8.CrossRefPubMed
14.
go back to reference Uchiyama K, Takifuji K, Tani M, Ueno M, Kawai M, Ozawa S, Yamaue H. Prevention of postoperative infections by administration of antimicrobial agents immediately before surgery for patients with gastrointestinal cancers. Hepatogastroenterology. 2007;54:1487–93.PubMed Uchiyama K, Takifuji K, Tani M, Ueno M, Kawai M, Ozawa S, Yamaue H. Prevention of postoperative infections by administration of antimicrobial agents immediately before surgery for patients with gastrointestinal cancers. Hepatogastroenterology. 2007;54:1487–93.PubMed
15.
go back to reference Zhang CD, Zeng YJ, Li Z, Chen J, Li HW, Zhang JK, Dai DQ. Extended antimicrobial prophylaxis after gastric cancer surgery: a systematic review and meta-analysis. World J Gastroenterol. 2013;19:2104–9.CrossRefPubMedCentralPubMed Zhang CD, Zeng YJ, Li Z, Chen J, Li HW, Zhang JK, Dai DQ. Extended antimicrobial prophylaxis after gastric cancer surgery: a systematic review and meta-analysis. World J Gastroenterol. 2013;19:2104–9.CrossRefPubMedCentralPubMed
Metadata
Title
Optimal duration of prophylactic antimicrobial administration and risk of postoperative infectious events in thoracic esophagectomy with three-field lymph node dissection: short-course versus prolonged antimicrobial administration
Authors
Takeo Fujita
Hiroyuki Daiko
Publication date
01-01-2015
Publisher
Springer Japan
Published in
Esophagus / Issue 1/2015
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-014-0451-7

Other articles of this Issue 1/2015

Esophagus 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.